| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |